Proteasome Blocker Brings Glaucoma Gene Therapy Closer

News   Jan 17, 2018 | Original Story from the University of Wisconsin-Madison

 
Proteasome Blocker Brings Glaucoma Gene Therapy Closer

To improve gene transfer to treat the blinding disease glaucoma, the front of an untreated eye (left) is compared to an eye (right) pre-treated with a gene delivery enhancer. The green marker reveals the expression of the gene introduced through gene therapy, showing improved delivery using the enhancer. Credit: Curtis Brandt/Paul Kaufman, University of Wisconsin-Madison

 
 
 

RELATED ARTICLES

A Mystery Solved: "Protein Cluedo" Reveals Enzyme Secrets

News

Scientists have used biosensors to solve questions about protein production which might seem familiar to mystery board game enthusiasts.

READ MORE

Can You Eat Cells? Computer Model Predicts Organisms that Use Phagocytosis

News

A computer model developed by Museum researchers may provide new insight into the origins of phagocytosis, the process by which single-celled organisms “eat” other cells as a means of absorbing nutrients or eliminating pathogens.

READ MORE

Protein Analysis Gives Insight into Parkinson's

News

A study has characterized levels of pathological proteins from throughout the bodies of Parkinson's Disease patients, revealing some surprising findings.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE